Shanghai Fudan Forward S&T Co

Shanghai Fudan Forward S&T Co Dividend Coverage

The Dividend Coverage Ratio of Shanghai Fudan Forward S&T Co (600624.SS) as of Oct 29, 2026 is -3.22. In the previous year, Dividend Coverage Ratio was 3.24 — a change of -199.35% (lower).

Dividend Coverage

-3.22

YoY

-199.35%

Last updated:

Dividend Coverage Ratio of Shanghai Fudan Forward S&T Co is 2020 -3.22 . Dividend Coverage Ratio of Shanghai Fudan Forward S&T Co was 2019 3.24 . It decreases by -199.35% lower compared to the previous year.

The Shanghai Fudan Forward S&T Co Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2014
2.31 CNY
Jan 1, 2015
4.31 CNY
Jan 1, 2016
2.46 CNY
Jan 1, 2017
2.47 CNY
Jan 1, 2018
2.51 CNY
Jan 1, 2019
3.24 CNY
Jan 1, 2020
-3.22 CNY
The Shanghai Fudan Forward S&T Co Dividend Coverage history
YEARDividend CoverageYoY
-3.22-199.35%
3.24+29.25%
2.51+1.44%
2.47+0.54%
2.46-43.03%
4.31+86.74%
2.31—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Shanghai Fudan Forward S&T Co Stock analysis

What does Shanghai Fudan Forward S&T Co do? Shanghai Fudan Forward S&T Co., Ltd. generates revenue through the research, development, production, and sale of pharmaceutical products, including digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory drugs, and immune function medications. The company also provides financial insurance software products. Its domestic and overseas markets serve as key sales channels for these pharmaceuticals and software solutions. The firm's product portfolio targets healthcare providers, hospitals, and pharmacies within the pharmaceutical sector. The company's pharmaceutical segment focuses on specialized drug categories such as digestive system and nervous system treatments, alongside antineoplastic and circulatory drugs. Financial insurance software products complement its core pharmaceutical business, offering additional revenue streams. Domestic markets account for a significant portion of sales, while overseas markets expand its global reach. Shanghai Fudan Forward S&T Co., Ltd. leverages its 1,426 full-time employees to support both pharmaceutical and software operations. The firm's product offerings cater to healthcare institutions requiring specialized medications and digital solutions for insurance management. This dual focus allows the company to serve multiple segments within the healthcare and financial technology industries. Shanghai Fudan Forward S&T Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Fudan Forward S&T Co stock

Dividend Coverage Ratio of Shanghai Fudan Forward S&T Co is -3.22 in 2020.

Dividend Coverage Ratio of Shanghai Fudan Forward S&T Co changed from 3.24 to -3.22, representing a -199.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Shanghai Fudan Forward S&T Co since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Shanghai Fudan Forward S&T Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dividend — Shanghai Fudan Forward S&T Co

DividendDividend YieldDividend per ShareYears Dividend PaidYears Dividend Not DecreasedYears Dividend IncreasedDividend Coverage

All Key Metrics — Shanghai Fudan Forward S&T Co